[1]
2025. Biomarker-Guided Drug Discovery for Diabetes Mellitus and Its Cardiometabolic Comorbidities. Annual Methodological Archive Research Review. 3, 9 (Sep. 2025), 75–87. DOI:https://doi.org/10.63075/ynbgya36.